Trials / Completed
CompletedNCT01908296
Study to Evaluate the Effect of Multiple-dose of Fluvoxamine on the Plasma Concentration of Quetiapine (FK949E) in Healthy Male Volunteers
Phase I Study of FK949E - A Study of Drug-drug Interactions Between FK949E and Fluvoxamine in Healthy Male Adults
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- Astellas Pharma Inc · Industry
- Sex
- Male
- Age
- 20 Years – 44 Years
- Healthy volunteers
- Accepted
Summary
The objective of the study was to assess the effect of multiple-dose fluvoxamine on the pharmacokinetics of quetiapine (FK949E) in healthy adult male subjects. The safety of FK949E in the population was also evaluated.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | FK949E | Oral |
| DRUG | fluvoxamine | Oral |
Timeline
- Start date
- 2011-07-01
- Primary completion
- 2011-08-01
- Completion
- 2011-08-01
- First posted
- 2013-07-25
- Last updated
- 2017-02-16
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT01908296. Inclusion in this directory is not an endorsement.